Actively Recruiting

Age: 0Months - 12Months
All Genders
ID04477460

Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event

Led by Boston Children's Hospital · Updated on 2026-03-18

250

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

B

Boston Children's Hospital

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study investigates infants who have experienced brief resolved unexplained events (BRUE), which are sudden, alarming episodes involving choking, color changes, and limpness. Researchers aim to understand how thickened feedings affect clinical outcomes and healthcare use in these infants, particularly focusing on swallowing difficulties that may contribute to ongoing symptoms. Participants are divided into two groups: those receiving thickened feeds and those receiving non-thickened feeds, both managed by their medical team. This observational study follows infants for one year to compare outcomes between these two feeding approaches. Throughout the study, researchers track the frequency of persistent symptoms and repeat hospitalizations over six months as the primary measure, with additional monitoring extending to 12 months. Data collection includes clinical assessments to understand swallowing function and symptom progression, providing insight into how feeding interventions may influence health over time.

CONDITIONS

Brief Title

Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event

Who Can Participate

Age: 0Months - 12Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Less than 1 year of age
  • Admitted to Boston Children's Hospital after experiencing first lifetime brief resolved unexplained event
Not Eligible

You will not qualify if you...

  • Any pre-existing medical diagnoses that exclude brief resolved unexplained event diagnosis including seizure disorders and cyanotic congenital heart disease
  • Already receiving thickened liquids for treatment of another condition

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 12 months

Participants who receive either thickened or non-thickened feeds are observed for clinical outcomes related to brief resolved unexplained events over time.

Periodic visits during the 12-month follow-up period

Trial Site Locations

Total: 1 location

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

D

Daniel R Duncan, MD, MPH

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Biological Determinants and Neural Compensatory Mechanisms o...

Parkinsons Disease (PD)

Actively Recruiting

1 location

Investigation of a Free Water Protocol for Patients with Oro...

Oropharyngeal Dysphagia

Actively Recruiting

2 locations

The Effect of Nursing Care Bundle on Oral Intake Among Criti...

Oropharyngeal Dysphagia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices.

Daniel R Duncan, Amanda S Growdon, Enju Liu...

https://pubmed.ncbi.nlm.nih.gov/31103259

Brief Resolved Unexplained Events Symptoms Frequently Result in Inappropriate Gastrointestinal Diagnoses and Treatment.

Daniel R Duncan, Clare Golden, Amanda S Growdon...

https://pubmed.ncbi.nlm.nih.gov/38815745